First In Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, GB
Roman Rothaermel(Founder)inInna Thalmann(Founder)inChris EijsboutsinKumeren Govnder
Co-investorsInitialized CapitalUnderscore VCVenrockY CombinatorArkitekt Ventures
Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.
BiotechCleantechClimate TechFoodTech
Co-investorsFTW VenturesS2G InvestmentsCRCM VenturesThird Kind Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.